We previously reported that Apcmin/+ mice deficient for Klrk1 (Apcmin/;Klrk1−/−) survive longer than Apcmin/+;Klrk1+/+ mice and displayed a lower tumor burden [30]. Here, KLRK1 is linked to neoplasm.